Access to medical supplies and devices —COVID-19 and medical monopoly
Access to existing medical technology, crucial to stemming spread of the novel coronavirus, is particularly lacking in the Global South due to monopoly control.
- Análisis
Discussions around access to potential vaccines for COVID-19 are widespread, particularly in the global South. Much less discussed is the lack of access to already existing medical technology crucial to stemming the spread of the novel coronavirus and assisting its most severely affected victims. The latter is the outcome of the monopoly control of medical technology — a phenomenon stretching at least as long as the monopoly of Big PHARMA — though much less understood.
Read the paper below.
Source: SouthViews, No. 208, 19 October 2020
South Centre
Del mismo autor
- Africa's COVID-19 vaccine and the scandal of the centuries 11/10/2021
- Movilizarse para una atención sanitaria desmercantilizada y COVID CERO 14/05/2021
- Fighting the medical monopoly: Mobilizing for ZERO-COVID and decommodified healthcare 15/03/2021
- Access to medical supplies and devices —COVID-19 and medical monopoly 23/10/2020
Clasificado en
Clasificado en:
Pandemia
- Gabriela Ramírez Mendoza 07/02/2022
- Jyotsna Singh 06/02/2022
- Gabriela Ramírez Mendoza 06/02/2022
- Richa Chintan 10/01/2022
- Isaac Enríquez Pérez 03/01/2022